Literature DB >> 3699029

S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.

K T Preissner, G Müller-Berghaus.   

Abstract

The interference of S protein with the heparin-catalyzed inhibition of thrombin by antithrombin III was studied in a purified system and in plasma. The effect of S protein to counteract heparin activity was documented by kinetic analysis of the initial phase of the inhibition reaction. Addition of S protein induced a concentration-dependent reduction of the inhibition rate, reflected in a decrease of the apparent pseudo-first-order rate constant by a factor of 5-8 in the presence of a twofold molar excess of S protein over antithrombin III. A non-competitive interaction of S protein with the thrombin--antithrombin-III--heparin inhibition reaction with Ki = 0.6 microM was found. While the association constant of thrombin--antithrombin III in the presence of 0.05 U/ml heparin amounted to 2.5 X 10(8) M-1, an approximately 200-fold decrease of this value was observed in the presence of S protein. The fast formation of the covalent complex between thrombin and antithrombin III in the presence of heparin was impaired as a result of the presence of S protein, as was shown by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. In the absence of heparin the inhibition of thrombin by antithrombin III alone was not influenced by S protein. The heparin-counteracting activity of S protein was found to be mainly expressed in the range of 0.01-0.1 U/ml heparin, thereby shifting the point of 50% inhibition of thrombin from 0.003 U/ml to 0.1 U/ml heparin with a second-order rate constant of k2 = 1.4 X 10(6) M-1. A direct interaction of S protein with heparin was demonstrated by crossed immunoelectrophoresis with purified proteins as well as in plasma and serum. The analysis of plasma and serum by crossed immunoelectrophoresis against rabbit anti-(human S protein) serum revealed an additional cathodal peak in the serum sample, resulting from the interaction of S protein with serum components. These findings not only indicate a direct interaction of S protein with heparin in the onset of the inhibition of thrombin by antithrombin-III--heparin, but also a contribution of S protein during enzyme-inhibitor complex formation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699029     DOI: 10.1111/j.1432-1033.1986.tb09626.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

Authors:  D Chain; B Korc-Grodzicki; T Kreizman; S Shaltiel
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice.

Authors:  N A Boyd; A R Bradwell; R A Thompson
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

3.  Vitronectin-binding staphylococci enhance surface-associated complement activation.

Authors:  F Lundberg; T Lea; A Ljungh
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Plasminogen in proliferative vitreoretinal disorders.

Authors:  P Esser; K Heimann; K U Bartz-Schmidt; P Walter; R Krott; M Weller
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

5.  Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli.

Authors:  G S Chhatwal; K T Preissner; G Müller-Berghaus; H Blobel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

6.  Immunohistochemical demonstration of vitronectin in association with elastin and amyloid deposits in human kidney.

Authors:  K Dahlbäck; H Löfberg; B Dahlbäck
Journal:  Histochemistry       Date:  1987

7.  Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.

Authors:  S Bhakdi; R Käflein; T S Halstensen; F Hugo; K T Preissner; T E Mollnes
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

8.  Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum.

Authors:  K T Preissner; L Zwicker; G Müller-Berghaus
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

Review 9.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

10.  New insights into heparin binding to vitronectin: studies with monoclonal antibodies.

Authors:  P Anne Underwood; Alan Kirkpatrick; Sue M Mitchell
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.